The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
Tinnitus is a persistent non-physiologic, non-psychiatric, ringing in the ear that affects up
to 20% of the general US population. The purpose of this study is to assess the patient
reported effectiveness of Xeomin (incobotulinumtoxinA) injections into the auricular muscles
for relief of tinnitus with use of the Tinnitus Handicap Inventory questionnaire.